IL 6 Measurement Using a New Densitometric Bedside (POC) Test
NCT00525369 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2007-09-05
Summary
In a equivalence analysis, we determined whether IL-6 can be assessed using a new densitometric point-of-care (POC) assay (turn-around -time: 20 minutes).IL-6 measurements were compared to test results obtained with conventional ELISA analysis
Conditions
- Sepsis, Septic Shock
Sponsors & Collaborators
-
Charite University, Berlin, Germany
lead OTHER
Principal Investigators
-
Hans-Georg Schlosser, MD · Charite University, Berlin, Germany
-
Joerg C Schefold, MD · Charite University, Berlin, Germany
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Germany
Study Locations
More Related Trials
-
Procalcitonin Ratio's Impact on the Decision Upon On-demand Relaparotomy in Septic Peritonitis
NCT01768936 ·Status: COMPLETED
-
Efficacy and Safety Study of CA330 Hemoadsorption Device on IL-6 Removal in Septic Patients
NCT03847961 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of Sepsis
NCT01995448 ·Status: COMPLETED
-
Can Measurement of Neutrophil-derived ROS Production be a Novel Biomarker of Sepsis?
NCT05968287 ·Status: COMPLETED
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
The Effect of Semi-quantitative Procalcitonin Assay to The Adequacy of Empirical Antibiotics and Mortality in Septic Patients
NCT01862185 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Symphony IL-6 Monitoring Sepsis ICU Study
NCT06181604 ·Status: COMPLETED
-
Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections
NCT00934011 ·Status: COMPLETED ·Phase: NA
-
Serial Body Composition Change for Risk Prediction and Nutritional Guide in Treating Patients With Sepsis
NCT04989569 ·Status: COMPLETED ·Phase: NA
-
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
NCT05640037 ·Status: COMPLETED
-
Evaluation of the IB10 Sphingotest PCT+ in a Point-of-Care Setting
NCT04529733 ·Status: UNKNOWN ·Phase: NA
-
Study of Subcutaneous Interstitial Pressure During Sepsis
NCT03818269 ·Status: COMPLETED ·Phase: NA
-
Effects of Enteral Nutrition Content on Disease Progression in Sepsis Patients
NCT06943326 ·Status: RECRUITING
-
CD64 and Antibiotics in Human Sepsis
NCT02922998 ·Status: COMPLETED
-
Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study
NCT06654895 ·Status: RECRUITING
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN
-
Early Detection of At-risk Septic Patients
NCT06253325 ·Status: RECRUITING
-
Immune Homeostasis in Sepsis and Septic Shock
NCT04448951 ·Status: RECRUITING
-
The Effect of Rapid Fluid Challenge Under Pulmonary Artery Catheter Monitoring on Physiological Indexes of Patients With Septic Shock
NCT03661268 ·Status: UNKNOWN ·Phase: NA
-
Platelets to Lymphocytes Ratio in Sepsis
NCT05399225 ·Status: UNKNOWN
-
Serum Proteomics Analysis for Sepsis
NCT01493466 ·Status: UNKNOWN
-
Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics
NCT03866083 ·Status: UNKNOWN ·Phase: NA
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Hemospec Device for Sepsis Diagnosis
NCT03350113 ·Status: COMPLETED ·Phase: NA
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT01535534 ·Status: UNKNOWN